Enlivex Therapeutics Ltd (ENLV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ENLV | ITRM | LPCN | ||
| Company | Enlivex Therapeutics Ltd | Iterum Therapeutics Plc | Lipocine Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 1.4700 | 1.5900 | 4.52 | ||
| High | 1.5000 | 1.7200 | 4.81 | ||
| Low | 1.4400 | 1.5200 | 4.51 | ||
| Last | 1.4400 | 1.6700 | 4.80 | ||
| Change | -0.0100 | +0.1000 | +0.25 | ||
| % Change | -0.69% | +6.37% | +5.44% | ||
| Volume | 58,100 | 106,200 | 19,700 | ||
| 20-Day Average Volume | 360,845 | 141,700 | 152,845 | ||
| Previous Close | 1.4500 | 1.5700 | 4.55 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | No | No | ||
| Technicals | |||||
| 20-Day Moving Average | 2.4805 | 1.5970 | 5.21 | ||
| 20-Day Raw Stochastic | 8.43% | 49.02% | 14.46% | ||
| 20-Day Relative Strength | 33.84% | 54.61% | 50.13% | ||
| Weighted Alpha | -50.46 | -36.88 | +0.10 | ||
| Today's Opinion | 24% Sell | 64% Buy | 80% Buy | ||
| Previous Opinion | 24% Sell | 32% Buy | 80% Buy | ||
| Last Month's Opinion | 100% Buy | 40% Buy | 88% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +9.09% since 04/19/24 | +16.78% since 04/19/24 | -8.96% since 04/19/24 | ||
| Low | 1.2400 on 04/22/24 | 1.4600 on 04/22/24 | 4.40 on 04/24/24 | ||
| High | 1.5300 on 04/24/24 | 1.7200 on 04/26/24 | 5.40 on 04/22/24 | ||
| 1-Month | |||||
| %Chg | -63.17% since 03/26/24 | +7.05% since 03/26/24 | -4.24% since 03/26/24 | ||
| Low | 1.1500 on 04/15/24 | 1.4200 on 04/19/24 | 4.40 on 04/24/24 | ||
| High | 4.5900 on 04/03/24 | 1.9300 on 04/04/24 | 7.15 on 04/11/24 | ||
| 3-Month | |||||
| %Chg | -48.01% since 01/26/24 | -2.91% since 01/26/24 | +23.33% since 01/26/24 | ||
| Low | 1.1500 on 04/15/24 | 1.2197 on 02/23/24 | 3.20 on 03/07/24 | ||
| High | 4.5900 on 04/03/24 | 2.3400 on 01/30/24 | 7.15 on 04/11/24 | ||
| 6-Month | |||||
| %Chg | +9.92% since 10/26/23 | +149.25% since 10/26/23 | +95.03% since 10/26/23 | ||
| Low | 1.1500 on 04/15/24 | 0.6420 on 10/31/23 | 2.31 on 10/30/23 | ||
| High | 4.5900 on 04/03/24 | 2.5000 on 11/27/23 | 7.15 on 04/11/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 26,735 | 27,433 | 25,658 | ||
| Shares Outstanding, K | 18,566 | 16,427 | 5,348 | ||
| Annual Sales | 0 | 0 | -2,850,000 | ||
| Annual Net Income | -29,070,000 | -38,370,000 | -16,350,000 | ||
| Last Quarter Sales | 0 | 0 | 220,000 | ||
| Last Quarter Net Income | -9,100,000 | -12,360,000 | -2,280,000 | ||
| 60-Month Beta | 1.02 | 2.36 | 1.05 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.48 on 03/29/24 | -0.94 on 03/28/24 | -0.42 on 03/07/24 | ||
| Latest Earnings Date | 06/21/24 | 05/10/24 | 05/09/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||